Drugs / CDFF0318
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04631874 | Jul 2019 → May 2020 | — | CTC Bio, Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CDFF0318 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04631874 ↗ |
| Known as | Varenicline salt | “CDFF0318: Varenicline salt changed Champix: Varenicline tartrate” NCT04631874 ↗ |